Results 81 to 90 of about 27,990 (252)

Cytomegalovirus-Related Immune Thrombocytopenic Purpura in an Immunocompetent Adult

open access: yesAnnals of Internal Medicine: Clinical Cases
We present the case of a 42-year-old immunocompetent man who was diagnosed with acute immune thrombocytopenic purpura and had evidence of an acute cytomegalovirus infection, concerning for secondary immune thrombocytopenic purpura.
Derek J. Essegian, Rachel A. Sibley
doaj   +1 more source

Immune Thrombocytopenic Purpura of Childhood

open access: yesHematology, 2006
Abstract Immune mediated thrombocytopenia (ITP) is a common manifestation of autoimmune disease in children. Although patients often present with bruises, petechiae, and some mucosal bleeding, the incidence of life-threatening hemorrhage is rare (0.2–0.9%) but can be fatal when presenting in vital organs.
openaire   +3 more sources

How we manage immune‐mediated thrombotic thrombocytopenic purpura after rituximab failure or intolerance

open access: yesBritish Journal of Haematology, Volume 206, Issue 6, Page 1560-1570, June 2025.
The use of rituximab as a pre‐emptive treatment in immune‐mediated thrombotic thrombocytopenic purpura (iTTP) is the current standard of care. However, for patients refractory to rituximab or for those with contraindication, further treatment guidelines are scarce.
Julia Weisinger   +4 more
wiley   +1 more source

Author Reply [PDF]

open access: yes, 2008
NO ABSTRACT ...
Abdul Rehman
core  

A case of refractory thrombotic thrombocytopenic purpura treated with plasmapheresis and rituximab [PDF]

open access: yes, 2016
Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening disorder with no prevalence or incidence studies in sub-Saharan Africa. Acquired TTP has several causes, all of which lead to decreased activity of von Willebrand factor cleaving ...
Kirui, Nicholas, Sokwala, Ahmed
core   +4 more sources

Prevalence of Immune Thrombocytopenia Purpura in Wasit Province

open access: yesWasit Journal for Pure Sciences
A lower than normal platelet count is a hallmark of the acquired autoimmune disease immune thrombocytopenic purpura (ITP). This autoimmune disease is characterized by low platelet counts, purpura, and hemorrhagic episodes caused by antiplatelet ...
Rawan Alaa
doaj   +1 more source

Thrombotic thrombocytopenic purpura [PDF]

open access: yes, 2015
Thrombotic thrombocytopenic purpura (TTP) is a disease with a high rate of mortality if a proper treatment is not instated. Plasmapheresis with plasmatic exchange is the treatment of choice. Diagnosis is performed demonstrating microangiopathic hemolytic
Gómez Almaguer, David   +2 more
core   +1 more source

Evaluation of Reticulin Fibrosis in Benign Hematologic Disorders in Lahore, Pakistan: A Cross-Sectional Study

open access: yesLife and Science
Objective: To assess reticulin fibrosis in benign hematologic disorders and to understand the impact of benign hematologic disorders on the immune system. Study Design: Cross-sectional study.
Yasir Shabbir   +5 more
doaj   +1 more source

Eltrombopag: an update on the novel, non-peptide thrombopoietin receptor agonist for the treatment of immune thrombocytopenia [PDF]

open access: yes, 2018
Immune thrombocytopenia (ITP) is characterised by a transient or persistent decrease in platelets accompanied by an increased risk of bleeding, which can have a significant negative impact on patients' health-related quality of life.
Imbach, Paul, Kühne, Thomas
core  

Is It a Coincidence or Secondary Immune Thrombocytopenic Purpura? A Case of an 11-Year-Old Male Patient at Hawassa University Comprehensive Specialized Hospital, Hawassa, Sidama, Ethiopia

open access: yesInternational Medical Case Reports Journal, 2022
Worku Ketema,1 Kefyalew Taye,1 Negash Tagesse,1 Aberash Eifa2 1Department of Paediatrics and Child Health, Hawassa University Comprehensive Specialized Hospital, Hawassa, Ethiopia; 2Department of Midwifery, Hawassa University Comprehensive Specialized ...
Ketema W, Taye K, Tagesse N, Eifa A
doaj  

Home - About - Disclaimer - Privacy